Compounds > 2-methoxyestradiol
Page last updated: 2024-08-24

2-methoxyestradiol and Experimental Mammary Neoplasms

2-methoxyestradiol has been researched along with Experimental Mammary Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gartel, AL; Halasi, M; Hay, N; Nogueira, V; Pandit, B; Wang, M1
D'Amato, R; Miller, KD; Sidor, C1
Calvo, A; Charles, R; Green, JE; Huh, JI1
Adlercreutz, H; Berger, MR; Lippert, TH; Mueck, AO; Seeger, H1
Cicek, M; Clohisy, DR; Goblirsch, MJ; Iwaniec, UT; Oursler, MJ; Ruan, M; Turner, RR; Vrabel, A1
Conney, AH; Zhu, BT1

Reviews

1 review(s) available for 2-methoxyestradiol and Experimental Mammary Neoplasms

ArticleYear
Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
    Cancer research, 1998, Jun-01, Volume: 58, Issue:11

    Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Transformation, Neoplastic; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Tumor Cells, Cultured

1998

Other Studies

5 other study(ies) available for 2-methoxyestradiol and Experimental Mammary Neoplasms

ArticleYear
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
    The American journal of pathology, 2013, Volume: 183, Issue:1

    Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Administration Schedule; Estradiol; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Humans; Isothiocyanates; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Oxidative Stress; Pyrazines; Random Allocation; Reactive Oxygen Species; RNA Interference; Transplantation, Heterologous; Treatment Outcome

2013
The potential and suitability of 2-methoxyestradiol in cancer therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16

    Topics: 2-Methoxyestradiol; Animals; Breast Neoplasms; Cell Line, Tumor; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Treatment Outcome; Xenograft Model Antitumor Assays

2005
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
    Cancer research, 2006, Apr-01, Volume: 66, Issue:7

    Topics: 2-Methoxyestradiol; Animals; Apoptosis; Cell Growth Processes; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Estradiol; Female; Inhibitor of Differentiation Protein 1; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasm Staging

2006
Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
    The Journal of steroid biochemistry and molecular biology, 2007, Volume: 103, Issue:2

    Topics: 2-Methoxyestradiol; Animals; Carcinoma; Coumestrol; Estradiol; Female; Isoflavones; Lignans; Mammary Neoplasms, Experimental; Methylnitrosourea; Phytoestrogens; Rats; Rats, Sprague-Dawley

2007
2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.
    Cancer research, 2007, Nov-01, Volume: 67, Issue:21

    Topics: 2-Methoxyestradiol; Animals; Bone Neoplasms; Cell Line, Tumor; Disease Progression; Dose-Response Relationship, Drug; Estradiol; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Osteoclasts; Osteolysis

2007